Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
04/18/2002 | CA2425672A1 Use of substituted imidazo[1,2-a]-pyridin-,pyrimidin-and -pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting nos |
04/18/2002 | CA2425666A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
04/18/2002 | CA2425650A1 Methods for the treatment of a traumatic central nervous system injury |
04/18/2002 | CA2425649A1 Nitroderivatives as drugs for diseases having an inflammatory basis |
04/18/2002 | CA2425581A1 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
04/18/2002 | CA2425520A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres |
04/18/2002 | CA2425508A1 Targeted therapeutic agents |
04/18/2002 | CA2425121A1 Ether compounds and compositions for cholesterol management and related uses |
04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
04/18/2002 | CA2424951A1 Beta-amino acid derivatives as integrin receptor antagonists |
04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
04/18/2002 | CA2424107A1 Sulfonylguanidines |
04/18/2002 | CA2424055A1 Medication delivery devices |
04/18/2002 | CA2423935A1 Substituted c-cyclohexylmethylamine derivatives |
04/18/2002 | CA2423515A1 Pyrazole derivatives for the treatment of viral diseases |
04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
04/17/2002 | EP1197556A1 Useful polypeptide |
04/17/2002 | EP1197553A1 Antisense nucleic acid against alphaV integrin |
04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
04/17/2002 | EP1197488A1 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
04/17/2002 | EP1197484A2 1H-Indole-3-glyoxylamide sPLA2 inhibitors |
04/17/2002 | EP1197225A1 REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP |
04/17/2002 | EP1197209A1 Percutaneously absorbable preparations |
04/17/2002 | EP1196579A2 Tryptase inhibitor |
04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
04/17/2002 | EP1196569A2 Electron transfer proteins |
04/17/2002 | EP1196567A2 Human immune response molecules |
04/17/2002 | EP1196450A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
04/17/2002 | EP1196440A2 Therapeutic peptides derived from subsequences of bpi |
04/17/2002 | EP1196433A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
04/17/2002 | EP1196432A2 FVIIa ANTAGONISTS |
04/17/2002 | EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES |
04/17/2002 | EP1196416A1 Substituted purine derivatives as inhibitors of cell adhesion |
04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
04/17/2002 | EP1196387A1 Azo amino acid derivatives for the treatment of neurological diseases |
04/17/2002 | EP1196373A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
04/17/2002 | EP1196191A1 Death domain containing receptor 5 |
04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
04/17/2002 | EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
04/17/2002 | EP1196169A1 Compounds having cytokine inhibitory activity |
04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
04/17/2002 | EP1196161A1 Selective inhibition of cyclooxygenase-2 |
04/17/2002 | EP1196160A1 A synergistic combination: gabapentin and pregabalin |
04/17/2002 | EP1196155A1 New use of compounds as antibacterial agents |
04/17/2002 | EP1196147A1 Oral liquid compositions |
04/17/2002 | EP1196136A1 Compositions comprising organosiloxane resins for delivering oral care substances |
04/17/2002 | EP1196135A1 Compositions comprising organosiloxane resins for delivering oral care substances |
04/17/2002 | EP1112079B1 Myrtle extract, preparation method and use |
04/17/2002 | EP0937038B1 Vitamin d analogues |
04/17/2002 | EP0934290B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
04/17/2002 | EP0880519B1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
04/17/2002 | EP0706395B1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
04/17/2002 | EP0660708B1 Phospholipids |
04/17/2002 | EP0607178B1 Methods for the isolation and fusion of cells |
04/17/2002 | EP0359783B2 Treatment of autoimmune diseases by oral administration of autoantigens |
04/17/2002 | CN1345376A Protease, gene therefor and use thereof |
04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
04/17/2002 | CN1345335A Melanocortin receptor ligands |
04/17/2002 | CN1345332A C-terminal modified (N-substituted)-2 indolylcarbonyldiptides as inhibitors of ICE/CED-3 family of cysteine proteases |
04/17/2002 | CN1345331A Method and composition for angiogenesis inhibition |
04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
04/17/2002 | CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
04/17/2002 | CN1345314A Amine derivatives as protease inhibitors |
04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
04/17/2002 | CN1345244A Herbal compositions and uses for treatment tof allergic reactions |
04/17/2002 | CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
04/17/2002 | CN1344755A Prep. of degradable polymer, pharmaceutical composition containing the same and its use |
04/17/2002 | CN1344560A Medicine mainly for treating arthralgia and apoplexy sequelae |
04/17/2002 | CN1344557A Kidney invigorating and arthralgia eliminating granule |
04/17/2002 | CN1344545A Chinese medicine prepn for treating rheumatoid arthritis and its prepn |
04/17/2002 | CN1344540A Application of calcium L-threonate in treating cartilage related diseases |
04/17/2002 | CN1082958C Alternate crystal form of tazofelone |
04/17/2002 | CN1082950C Quinoline derivatives containing diol as leukotriene antagonists |
04/17/2002 | CN1082820C Purified extract of harpagophytum procumbens and/or Harpagophytum zeyherii DENCE, process for its prodn. and its use |
04/16/2002 | US6372926 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof |
04/16/2002 | US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups |
04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
04/16/2002 | US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles |
04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
04/16/2002 | US6372756 Narcotics or analgesics |
04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
04/16/2002 | US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
04/16/2002 | US6372731 Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
04/16/2002 | US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents |
04/16/2002 | US6372715 Use of erythropoientin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
04/16/2002 | US6372197 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |